ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

Rosen Law Firm has filed a class action lawsuit on behalf of Ardelyx, Inc. (NASDAQ: ARDX) investors who purchased stock between January 13, 2025 and August 6, 2026. The lawsuit alleges that defendants made materially false and misleading statements about the company's commercial performance and growth prospects for drugs XPHOZAH and IBSRELA, while concealing information about payer-related access barriers, prior authorization requirements, and step edit requirements that hindered patient access and new-patient starts. The deadline to serve as lead plaintiff is November 16, 2026.